// App-Quantinova.ai

5062 : The Role of Previous Thrombotic Events in Patients with Essential Thrombocythemia: The Earlier the Worse?

Researchers

Presenter

  • Marco Montanaro

Principal Investigators

  • Massimo Breccia

  • Erminia Baldacci

  • Cinzia De Gregoris

  • Barbara Anaclerico

  • Stefano Felici

  • Carla Ruscio

  • Jonny Di Giandomenico

  • Luca Franceschini

  • Gloria Pessina

  • Giuseppe Cimino

  • Nicoletta Villiva

  • Enrico Montefusco

  • Agostino Tafuri

  • Giuseppe Avvisati

  • Ignazio Majolino

  • Maria Gabriella Mazzucconi

  • Giuliana Alimena

  • Alessandro Andriani

  • Raffaele Porrini

  • Francesca Spirito

  • Angela Rago

  • Sabrina Leonetti Crescenzi

  • Antonio Spadea

  • Marianna De Muro

  • Ettore Cotroneo

Medical Centers

  • Hematology Division, S.Andrea Hospital, Sapienza University, Rome, Italy

  • Hematology, University Tor Vergata, Rome, Italy

  • Hematology, San Camillo Hospital, Rome, Italy

  • Dermatologic Unit ,San Camillo-Forlanini Hospital, Rome, Italy

  • Division of Hematology, Sapienza University, Rome, Italy

  • Campus Biomedico University, Rome, Italy

  • Cellular Biotechnologies and Hematology, SAPIENZA UNIVERSITY, Rome, Italy

  • Belcolle Hospital, Viterbo, Hematology,

  • Hematology Unit, Policlinico Universitario Tor Vergata, Rome, Italy

  • Hematology Unit, SantAndrea Hospital, Roma, Italy

  • Hematology, Ospedale San Camillo Forlanini, Roma, Italy

  • Hematology, Nuovo Regina Margherita Hospital, Roma, Italy

  • Cellular Biotechnologies and Hematology, University of Rome La Sapienza, Rome, Italy

  • Hematology Division, S.Giovanni Addolorata Hospital,

  • Cellular Biotechnologies and Hematology, University of Rome La Sapienza, Rome, Italy

  • Hematology, Belcolle Hospital, Viterbo, Italy

  • Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Rome, Italy

  • Hematology, IFO, Rome, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Essential thrombocythemia

  • Pulmonary arterial hypertension

  • Hypercholesterolemia, Familial, 1

  • Hypertension

  • Venous thrombosis

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim